$FTRE News
Last published 1w ago
- 1w agoFTREFortrea Q3'26 Earnings Conference Call - FORTREA HOLDINGS INCEarnings Call TranscriptsThank you for standing by and welcome to Fortria's third quarter 2026 earnings conference call. Currently, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer
- 1w agoFTREFortrea Holdings Inc. - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 9.01
- 1w agoFTREFortrea Reports Third Quarter 2026 ResultsGlobeNewswireHighlights For the three months ended September 30, 2026: Revenues of $691.5 millionBook-to-bill ratio of 1.12x, resulting in 1.12x book-to-bill for the trailing 12 monthsGAAP net income of $0.6 million, or $0.01 per
- 2w agoFTREFortrea to Participate in Jefferies Global Healthcare ConferenceGlobeNewswireDURHAM, N.C., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Fortrea (NASDAQ:FTRE), a leading global contract research organization ("CRO"), today announced that CEO Anshul Thakral, CFO Jason Knoblauch, and SVP of Investor
- 2w agoFTREFortrea and Omico Collaboration to Advance Biomarker-led Oncology Drug DevelopmentGlobeNewswireHighlights Collaboration aims to accelerate precision oncology research in AustraliaCombines Fortrea’s experience in oncology clinical trials with Omico’s Precision Oncology Screening Platform Enabling Clinical Trials
- 3w agoFTREFortrea Completes Acquisition of the Early Phase Services Division from Worldwide Clinical TrialsGlobeNewswireHighlights Fortrea completes acquisition of the Early Phase Services division from Worldwide Clinical TrialsAdds a 60,000-square-foot GLP-compliant bioanalytical laboratory in Austin, Texas; a 200-bed GCP-compliant
- 2mo agoFTREFortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswireDURHAM, N.C., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Fortrea (NASDAQ:FTRE) (the "Company"), a leading global contract research organization ("CRO"), today announced the granting of an inducement award of
- 2mo agoFTREFortrea to Participate in September Investor ConferencesGlobeNewswireDURHAM, N.C., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Fortrea (NASDAQ:FTRE), a leading global contract research organization ("CRO"), today announced that CEO Anshul Thakral, CFO Jason Knoblauch, and SVP of
- 2mo agoFTREFortrea to Acquire Clinical Pharmacology Unit and Bioanalytical Laboratory Operations from Worldwide Clinical TrialsGlobeNewswireHighlights Fortrea enters into a definitive agreement to acquire the Early Phase Services division of Worldwide Clinical TrialsIncludes a 60,000 sq. ft. GLP bioanalytical lab in Austin; a 200-bed GCP-compliant clinical
- 3mo agoFTREFortrea Reports Second Quarter 2026 ResultsGlobeNewswireFour consecutive quarters of execution to drive commercial, operational and financial excellence Increases full-year guidance Highlights For the three months ended June 30, 2026: Revenues of $678.2
- 4mo agoFTREFortrea Announces Date for Second Quarter 2026 Financial Results and Conference CallGlobeNewswireDURHAM, N.C., July 13, 2026 (GLOBE NEWSWIRE) -- Fortrea (NASDAQ:FTRE) (the "Company"), a leading global contract research organization (CRO), today announced that it will release its second quarter 2026
- 4mo agoFTREFortrea Names Jason Knoblauch as Chief Financial OfficerGlobeNewswireDURHAM, N.C., June 26, 2026 (GLOBE NEWSWIRE) -- Fortrea (NASDAQ:FTRE) (the "Company"), a leading global contract research organization (CRO), today announced that Jason Knoblauch has been appointed as chief
- 5mo agoFTREFortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswireDURHAM, N.C., June 10, 2026 (GLOBE NEWSWIRE) -- Fortrea (NASDAQ:FTRE) (the "Company"), a leading global contract research organization ("CRO"), today announced the granting of an inducement award of restricted stock
- 5mo agoFTREFortrea to Attend Jefferies Global Healthcare ConferenceGlobeNewswireDURHAM, N.C., June 02, 2026 (GLOBE NEWSWIRE) -- Fortrea (NASDAQ:FTRE), a leading global contract research organization ("CRO"), today announced that that CEO Anshul Thakral, CFO Jill McConnell, and SVP of Investor
- 6mo agoFTREFortrea Reports First Quarter 2026 ResultsGlobeNewswireStrong first-quarter performance reinforces confidence in FY 2026 guidanceBook-to-bill of 1.15x is third consecutive quarter above 1.1x Highlights For the three months ended March 31, 2026: Revenues of $636.5
- 6mo agoFTREFortrea Announces Date for First Quarter 2026 Financial Results and Conference CallGlobeNewswireDURHAM, N.C., April 21, 2026 (GLOBE NEWSWIRE) -- Fortrea (NASDAQ:FTRE) (the "Company"), a leading global contract research organization (CRO), today announced that it will release its first quarter 2026 financial
- 7mo agoFTREFortrea Unveils Fortrea Intelligent Technology™ to Help Sponsors and Sites Run Smarter, More Integrated TrialsGlobeNewswireHighlights: Designed to transform clinical trial operations for sponsors, sites and study teamsPersona driven, AI-powered solutions automate workflows and streamline oversight to help improve trial speed, predictability
- 8mo agoFTREFortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswireDURHAM, N.C., March 10, 2026 (GLOBE NEWSWIRE) -- Fortrea (NASDAQ:FTRE) (the "Company"), a leading global contract research organization, today announced the granting of an inducement award of restricted stock units
- 8mo agoFTREFortrea Reports Fourth Quarter and Full-Year 2025 Results; Issues Full-Year 2026 GuidanceGlobeNewswireRevenue and Adjusted EBITDA results delivered in line with stated full-year targetsFull‑year cost savings exceeded previously communicated targets Highlights: Revenues of $660.5 million for the fourth quarter and
- 8mo agoFTREFortrea Expands Executive Team, Appointing Oren Cohen as Chief Medical Officer and Scott Dove as President of Clinical Pharmacology ServicesGlobeNewswireDURHAM, N.C., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Fortrea (NASDAQ:FTRE) (the "Company"), a leading global contract research organization (CRO), today announced it has expanded its executive team. Oren Cohen, MD who
- 9mo agoFTREFortrea Announces Date for Fourth Quarter and Full Year 2025 Financial Results and Conference CallGlobeNewswireDURHAM, N.C., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Fortrea (NASDAQ:FTRE) (the "Company"), a leading global contract research organization (CRO), today announced that it will release its fourth quarter and full year 2025
- 10mo agoFTREFortrea Announces Updated Presentation Time at Upcoming J.P. Morgan Healthcare ConferenceGlobeNewswireDURHAM, N.C., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Fortrea (NASDAQ:FTRE), a leading global contract research organization (CRO), today announced an updated presentation time of 11:15 am PST on Tuesday, January 13, 2026,
- 11mo agoCYTKFTREMOHSNPSNotice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Molina Healthcare, Inc. (NYSE: MOH); and Synopsys, Inc. (NASDAQ: SNPS): Grabar Law Office Investigates Claims on Your BehalfGlobeNewswirePHILADELPHIA, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (NASDAQ:CYTK): Grabar Law Office is investigating claims on behalf of shareholders of Cytokinetics, Inc. (NASDAQ:CYTK). The investigation concerns
- 11mo agoCYTKFTRESNPSWBTNNotice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Synopsys, Inc. (NASDAQ: SNPS); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your BehalfGlobeNewswirePHILADELPHIA, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (NASDAQ:CYTK): Grabar Law Office is investigating claims on behalf of shareholders of Cytokinetics, Inc. (NASDAQ:CYTK). The investigation concerns
- 11mo agoAREFTREKMXSTUBImportant Notice to Long-Term Shareholders of Alexandria Real Estate Equities, Inc. (NYSE: ARE); CarMax, Inc. (NYSE: KMX); Fortrea Holdings, Inc. (NASDAQ: FTRE); StubHub Holdings, Inc. (NYSE: STUB): Grabar Law Office Investigates Claims on Your BehalfGlobeNewswirePHILADELPHIA, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Alexandria Real Estate Equities, Inc. (NYSE:ARE): Grabar Law Office is investigating claims on behalf of shareholders of Alexandria Real Estate Equities,
- 11mo agoFTREFortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswireDURHAM, N.C., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Fortrea (NASDAQ:FTRE) (the "Company"), a leading global contract research organization, today announced the granting of an inducement award of restricted stock units
- 11mo agoANSSCYTKFTRESNPS+1Attention Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Synopsys, Inc. (NASDAQ: SNPS); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your BehalfGlobeNewswirePHILADELPHIA, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (NASDAQ:CYTK): Grabar Law Office is investigating claims on behalf of shareholders of Cytokinetics, Inc. (NASDAQ:CYTK). The investigation concerns
- 11mo agoFTRESCTbio and Fortrea Forge Strategic Collaboration to Accelerate Cell and Gene Therapy Development and DeliveryGlobeNewswirePRAGUE, Czech Republic and DURHAM, N.C., Dec. 04, 2025 (GLOBE NEWSWIRE) -- SCTbio, a leading European CDMO specializing in GMP manufacturing for cell-based products, and Fortrea, a leading global contract research
- 11mo agoCYTKFTREUNCYWBTNImportant Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Unicycive Therapeutics, Inc. (NASDAQ: UNCY); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office is Investigating Claims on Your BehalfGlobeNewswirePHILADELPHIA, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (NASDAQ:CYTK): Grabar Law Office is investigating claims on behalf of shareholders of Cytokinetics, Inc. (NASDAQ:CYTK). The investigation concerns
- 11mo agoCYTKFTREIBTAWBTNImportant Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Ibotta, Inc. (NYSE: IBTA); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office is Investigating Claims on Your BehalfGlobeNewswirePHILADELPHIA, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (NASDAQ:CYTK): Grabar Law Office is investigating claims on behalf of shareholders of Cytokinetics, Inc. (NASDAQ:CYTK). The investigation concerns
- 11mo agoCYTKFTREINSPWBTNImportant Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Inspire Medical Systems, Inc. (NYSE: INSP); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office is Investigating Claims on Your BehalfGlobeNewswirePHILADELPHIA, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (NASDAQ:CYTK): Grabar Law Office is investigating claims on behalf of shareholders of Cytokinetics, Inc. (NASDAQ:CYTK). The investigation concerns
- 11mo agoFTREFortrea to Present at Upcoming Citi and Evercore Healthcare ConferencesGlobeNewswireDURHAM, N.C., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Fortrea (NASDAQ:FTRE), a leading global contract research organization (CRO), today announced that chief executive officer, Anshul Thakral, chief financial officer, Jill
- 11mo agoEUFTREHUMWBTNAttention Long-Term Shareholders of Fortrea Holdings, Inc. (NASDAQ: FTRE); enCore Energy Corp. (NASDAQ: EU); Humana Inc. (NYSE: HUM); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your BehalfGlobeNewswirePHILADELPHIA, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Fortrea Holdings, Inc. (NASDAQ:FTRE): Grabar Law Office is investigating claims on behalf of shareholders of Fortrea Holdings, Inc. (NASDAQ:FTRE). The investigation
- 11mo agoFTREFortrea Completes $75.7 Million Senior Notes Tender Offer Utilizing Cash on HandGlobeNewswireDURHAM, N.C., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Fortrea (NASDAQ:FTRE) (the "Company"), a leading global contract research organization (CRO), today announced that it has completed its debt tender offer (the "Tender
- 11mo agoFTREHUMLRNWBTNAttention Long-Term Shareholders of Fortrea Holdings, Inc. (NASDAQ: FTRE); Humana Inc. (NYSE: HUM); Stride Inc. (NYSE: LRN); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your BehalfGlobeNewswirePHILADELPHIA, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Fortrea Holdings, Inc. (NASDAQ:FTRE): Grabar Law Office is investigating claims on behalf of shareholders of Fortrea Holdings, Inc. (NASDAQ:FTRE). The
- 11mo agoCYTKFTREIBTALRNImportant Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Ibotta, Inc. (NYSE: IBTA); and Stride, Inc. (NYSE: LRN): Grabar Law Office is Investigating Claims on Your BehalfGlobeNewswirePHILADELPHIA, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (NASDAQ:CYTK): Grabar Law Office is investigating claims on behalf of shareholders of Cytokinetics, Inc. (NASDAQ:CYTK). The investigation concerns
- 11mo agoCYTKEUFTREIBTAImportant Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); enCore Energy Corp. (NASDAQ: EU); Fluor Corporation (NYSE: FLR); Fortrea Holdings, Inc. (NASDAQ: FTRE); and Ibotta, Inc. (NYSE: IBTA): Grabar Law Office is Investigating Claims on Your BehalfGlobeNewswirePHILADELPHIA, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (NASDAQ:CYTK): Grabar Law Office is investigating claims on behalf of shareholders of Cytokinetics, Inc. (NASDAQ:CYTK). The investigation concerns
- 11mo agoEUFLRFTREIBTAImportant Notice to Long-Term Shareholders of enCore Energy Corp. (NASDAQ: EU); Fluor Corporation (NYSE: FLR); Fortrea Holdings, Inc. (NASDAQ: FTRE); and Ibotta, Inc. (NYSE: IBTA): Grabar Law Office is Investigating Claims on Your BehalfGlobeNewswirePHILADELPHIA, Nov. 17, 2025 (GLOBE NEWSWIRE) -- enCore Energy Corp. (NASDAQ:EU): Grabar Law Office is investigating claims on behalf of shareholders of enCore Energy Corp. (NASDAQ:EU). The investigation concerns
- 11mo agoFTREFortrea Appoints Agnieszka Gallagher as General CounselGlobeNewswireDURHAM, N.C., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Fortrea (NASDAQ:FTRE) (the "Company"), a leading global contract research organization (CRO), today announced the appointment of Agnieszka (Aggie) M. Gallagher as general
- 12mo agoAVTREUFTRELRNImportant Notice to Long-Term Shareholders of Avantor, Inc. (NYSE: AVTR); enCore Energy Corp. (NASDAQ: EU); Fortrea Holdings, Inc. (NASDAQ: FTRE); and Stride, Inc. (NYSE: LRN): Grabar Law Office Investigates Claims on Your BehalfGlobeNewswirePHILADELPHIA, Nov. 15, 2025 (GLOBE NEWSWIRE) -- Avantor, Inc. (NYSE:AVTR): Grabar Law Office is investigating claims on behalf of shareholders of Avantor, Inc. (NYSE:AVTR). The investigation concerns whether certain
- 1y agoFTREFortrea Reports Third Quarter 2025 ResultsGlobeNewswireFor the three months ended September 30, 2025, from continuing operations: Revenues of $701.3 millionGAAP net loss of $(15.9) millionAdjusted EBITDA of $50.7 millionGAAP and adjusted net (loss) income per diluted share
- 1y agoFTREFortrea Announces Tender Offer for up to $75,744,000 Aggregate Purchase Price of Outstanding DebtGlobeNewswireDURHAM, N.C., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Fortrea (NASDAQ:FTRE) (the "Company"), a leading global contract research organization ("CRO"), today announced that it has commenced a debt tender offer (the "Tender
- 1y agoFTREFortrea Announces Date for Third Quarter 2025 Financial Results and Conference CallGlobeNewswireDURHAM, N.C., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Fortrea (NASDAQ:FTRE) (the "Company"), a leading global contract research organization (CRO), today announced that it will release its third quarter 2025 financial
- 1y agoFTREFortrea Origins - FortreaEarnings Call TranscriptsBeginning as one of the first CROs, Our Heritage is rooted in more than 30 years of product development expertise. Fortrea provides Phase 1 through 4 clinical trial management, clinical pharmacology and consulting servic
- 1y agoFTREFortrea Appoints William Sharbaugh to Board of DirectorsGlobeNewswireDURHAM, N.C., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Fortrea (NASDAQ:FTRE) (the "Company"), a leading global contract research organization (CRO), today announced the appointment of William Sharbaugh to the Company's
- 1y agoFTREFortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswireDURHAM, N.C., Sept. 12, 2025 (GLOBE NEWSWIRE) -- Fortrea (NASDAQ:FTRE) (the "Company"), a leading global contract research organization, today announced the granting of an inducement award of restricted stock units
- 1y agoFTREKuehn Law Encourages Investors of Fortrea Holdings, Inc. to Contact Law FirmPR NewswireKuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Fortrea Holdings, Inc. (NASDAQ: FTRE)...
- 1y agoFTREFortrea Holdings Inc. (FTRE) Q2 2025 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoFTREFortrea Reports Second Quarter 2025 ResultsGlobeNewswireFor the three months ended June 30, 2025, from continuing operations: Revenues of $710.3 millionGAAP net loss of $(374.9) million, inclusive of a non-cash goodwill impairment chargeAdjusted EBITDA of $54.9 millionGAAP
- 1y agoFTREFortrea Appoints Tracy Krumme as Senior Vice President, Investor RelationsGlobeNewswireDURHAM, N.C., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Fortrea (NASDAQ:FTRE), a leading global contract research organization (CRO), today announced the appointment of Tracy Krumme as senior vice president, investor